EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Monitoring pediatric CNS non‐germinomatous germ cell tumors via cerebrospinal fluid circulating tumor DNA

Yu-Tong Zhang, Xian-Mei Jin, Xiao-Dan Zhong iD, Jian Chang iD

Pediatric Blood & Cancer · 2024

DOI: 10.1002/pbc.31288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Yu-Tong Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Children Hospital of the First Hospital of Jilin University, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Neoplasms, Germ Cell and Embryonal, Circulating Tumor DNA, Biomarkers, Tumor, Central Nervous System Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jilin provincial Department of Finance, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Accurate molecular and clinical stratification of patients with central nervous system (CNS) non‐germinomatous germ cell tumors (NGGCTs) remains challenging, impeding the development of personalized therapeutic approaches. Herein, we investigated the translational significance of cerebrospinal fluid (CSF) circulating tumor DNA (ctDNA) in pediatric NGGCTs to identify characteristic features of CNS NGGCTs and to identify a subset of patients for whom the presence of residual disease is a risk factor and an indicator of shorter progression‐free survival (PFS) and overall survival (OS).

Methods

Medical records of patients with CNS NGGCTs between January 1, 2018 and December 31, 2022 were reviewed retrospectively.

Results

The cohort consisted of 11 male and six female patients. Tumor markers were elevated in four of the five people who underwent surgery. The remaining 12 patients were diagnosed with malignant NGGCTs according to elevated tumor markers. Among them, ctDNA before chemotherapy as well as ctDNA clearance were consistently associated with PFS and OS ( p < .05). By setting a ctDNA positivity threshold of 6%, patients with high ctDNA (above the threshold) levels, which had limitation due to the selection based on optimal statistic from the survival analysis, had significantly inferior 5‐year PFS and OS compared to those with low levels (below the threshold). ctDNA or ctDNA clearance combined with the presence of residual disease predicted significantly worse OS and PFS ( p < .05).

Conclusions

CSF ctDNA might allow the study of genomic evolution and the characterization of tumors in pediatric NGGCTs. CSF ctDNA analysis may facilitate the clinical management of pediatric NGGCT patients, and aid in designing personalized therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasms, Germ Cell and EmbryonalCirculating Tumor DNABiomarkers, TumorCentral Nervous System NeoplasmsHumansMaleFemaleChildRetrospective StudiesAdolescentChild, PreschoolPrognosisSurvival RateFollow-Up StudiesInfantNeoplasm, ResidualTesticular Neoplasms

Stichwörter der Autor:innen

cerebrospinal fluidcirculating tumor DNAnon‐germinomatous germ cell tumorspediatric

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pediatric Oncology, Children Hospital of the First Hospital of Jilin University, Changchun, Jilin, China.

ORCID-Profile: Xiao-Dan Zhong, Jian Chang

Förderung

  • Jilin provincial Department of Finance, China

Zitieren

APA

Zhang, Y. T., Jin, X. M., Zhong, X. D., & Chang, J. (2024). Monitoring pediatric CNS non‐germinomatous germ cell tumors via cerebrospinal fluid circulating tumor DNA. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31288

Vancouver

Zhang YT, Jin XM, Zhong XD, Chang J. Monitoring pediatric CNS non‐germinomatous germ cell tumors via cerebrospinal fluid circulating tumor DNA. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31288

BibTeX
@article{Zhang2024,
  author = {Zhang, Yu-Tong and Jin, Xian-Mei and Zhong, Xiao-Dan and Chang, Jian},
  title = {Monitoring pediatric CNS non‐germinomatous germ cell tumors via cerebrospinal fluid circulating tumor DNA},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  doi = {10.1002/pbc.31288}
}
Kostenlos starten →